Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy.
Mona AriamaneshPejman PorouhanBabak PeyroShabanyDanial Fazilat-PanahMansoureh DehghaniMaryam NabavifardFarbod HatamiMohammad FereidouniJames S WelshSeyed Alireza JavadiniaPublished in: Cancer investigation (2021)
The result of study confirmed the safety and short-term efficacy of inactivated vaccine in patients with malignancies.
Keyphrases